Status:

COMPLETED

Endoscopic Grading of Intestinal Metaplasia

Lead Sponsor:

Soonchunhyang University Hospital

Conditions:

Narrow-band Imaging

Magnifying Endoscopy

Eligibility:

All Genders

20-80 years

Brief Summary

Long-term Helicobacter pylori infection causes premalignant gastric conditions, such as atrophic gastritis and intestinal metaplasia. Image-enhanced endoscopy techniques such as narrow-band imaging (N...

Detailed Description

This study aims to evaluate the diagnostic performance of NBI and magnifying endoscopy for GIM in a country with high risk of gastric premalignant lesions.

Eligibility Criteria

Inclusion

  • Gastroscopy can be performed
  • Pathological analysis can be performed for analysis of gastric atrophy and intestinal metaplasia

Exclusion

  • Age \< 20 or \> 80 years
  • Anemia (serum hemoglobin level \< 10 g/dL)
  • Severe systemic disease
  • Advanced chronic liver disease
  • Use of certain medications, including proton pump inhibitors, H2-receptor antagonists, or antibiotics
  • History of H. pylori eradication
  • History of gastric surgery
  • Recent history of upper gastrointestinal bleeding

Key Trial Info

Start Date :

March 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 24 2023

Estimated Enrollment :

242 Patients enrolled

Trial Details

Trial ID

NCT05345314

Start Date

March 1 2022

End Date

April 24 2023

Last Update

April 25 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Digestive Disease Center, Soonchunhyang University Hospital

Seoul, South Korea, 140-887

Endoscopic Grading of Intestinal Metaplasia | DecenTrialz